N/A
N=1,094
Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites
Smoking Cessation
Bottom Line
View on ClinicalTrials.gov: NCT03291587 ↗Enrolled (actual)
1,094
Serious AEs
—
Results posted
Jul 2022
Primary outcome: Primary: Percentage of Patients With 7-day Sustained Smoking Abstinence Reported in the Patient Survey — 13.0; 13.5 percentage of participants — p=0.865
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Personnel Training and Coaching Calls (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Feb 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Patients With 7-day Sustained Smoking Abstinence Reported in the Patient Survey |
13.0; 13.5 | 0.865 |
| SECONDARY Salivary Cotinine Test for Non-Smokers |
13; 10; 10; 20; 28; 31 | — |
| SECONDARY Short-term Smoking Abstinence - Patient Survey |
6.5; 5.5 | — |
| SECONDARY Total Number of Services Participant Reported Received at 14 Days |
7.51; 7.86 | — |
Summary
Evaluate a multi-faceted training program to improve short-term smoking cessation rates (<14 days post-visit) and short (3 months) and sustained abstinence (6 months) among 1,114 enrolled smokers who present for low-dose computed tomography (LDCT) lung cancer screening in 26 community-based practices.
Eligibility Criteria
Inclusion Criteria
- Agrees to have NCORP research personnel serve as the study liaison and another person to serve as the cessation program champion.
- Agrees to participate in all aspects of the intervention, randomization, and evaluation.
- Agrees to participate in a confidential 1-on-1 semi-structured interview with the research team.
- Agrees to have the interview taped, transcribed and qualitatively analyzed.
- Age ≥18 years
- Potential participants will be screened using the following question: "Do you smoke cigarettes every day, some days, or not at all?" (BRFSS). A current smoker is anyone responds "every day" or "some days".
Exclusion Criteria
- Current use (previous 30 days) of a tobacco dependence treatment including bupropion, varenicline, and nicotine replacement
- Individuals who use e-cigarettes and who are not smoking cigarettes. Dual users (those who use both e-cigarettes and cigarettes) will still be included in the trial.
- The presence of a physical or cognitive impairment that would prevent a person from engaging in survey research (such as blindness, deafness, or dementia).
- Individual has already completed the intended LDCT lung cancer screening for this study.
- Non-English speaking participants.
Data sourced from ClinicalTrials.gov (NCT03291587). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.